Similar to that which has been discussed in depth. The growth data and recent investment in marketing looks to be significant.
The alteration from loss making to breakeven and or profitability is generally the game changer and is what drew my initial interest in this stock despite being beaten down.
I'm just hopeful that costs haven't sky rocketed without significant sales occurring and put a dampener on the bottom line.
Nova Eye Medical (EYE) Discussion, page-3169
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $62.92M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 27.5¢ | $105.1K | 377.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99735 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 39325 | 2 |
View Market Depth
| Last trade - 15.59pm 16/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |